Peptide YY (3-36) represents a high percentage of total PYY immunoreactivity in preterm and full-term infants and correlates independently with markers of adiposity and serum ghrelin concentrations

Pediatric Research

Volumn 62, Issue 2, 2007, Pages 200-203

  Siahanidou, Tania ^a   Mandyla, Helen ^a   Militsi, Helen ^b   Papassotiriou, Ioannis ^b   Chrousos, George ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; INSULIN; LEPTIN; PEPTIDE YY;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOOD INTAKE; GESTATIONAL AGE; GROWTH RATE; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; INFANT; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEWBORN; OBESITY; PREMATURITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; WEIGHT GAIN;

ADIPONECTIN; ADIPOSITY; BODY MASS INDEX; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; GESTATIONAL AGE; HOMEOSTASIS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN; LEPTIN; MALE; PEPTIDE HORMONES; PEPTIDE YY; RADIOIMMUNOASSAY; WEIGHT GAIN;

EID: 34547619380     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3180a76dad     Document Type: Article

References (26)

1. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR 1994 Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51:151-159
2. Onaga T, Zabielski R, Kato S 2002 Multiple regulation of peptide YY secretion in the digestive tract. Peptides 23:279-290
3. Chelikani PK, Haver AC, Reidelberger RD 2005 Intravenous infusion of PYY(3-36) potently inhibits food intake in rats. Endocrinology 146:879-888
4. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatel MA, Cone RD, Bloom SR 2002 Gut hormone PYY (3-36) physiologically inhibits food intake. Nature 418:650-654
5. Schwartz MW, Morton GJ 2002 Keeping hunger at bay. Nature 418:595-597
6. Meier U, Gressner AM 2004 Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 50:1511-1525
7. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R 1991 New Ballard Score, expanded to include extremely premature infants. J Pediatr 119:417-423
8. Volpe JJ 2001 Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage of the premature infant. In: Volpe JJ (ed) Neurology of the newborn. WB Saunders, Philadelphia, pp 428-493
9. Siahanidou T, Mandyla H, Vounatsou M, Anagnostakis D, Papassotiriou I, Chrousos GP 2005 Circulating levels of PYY are higher in preterm than term infants and correlate negatively with body weight and positively with serum ghrelin levels. Clin Chem 51:2131-2137
10. Siahanidou T, Mandyla H, Papassotiriou GP, Papassotiriou I, Chrousos G 2006 Circulating levels of adiponectin in preterm infants. Arch Dis Child Fetal Neonatal Ed [Epub ahead of print]
11. Roth CL, Enriori PJ, Woelfle J, Cowley MA, Reinehr T 2005 Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss. J Clin Endocrinol Metab 90:6386-6391
12. Rigo J, Nyamugabo K, Picaud JC, Gererd P, Pieltain C, De Curtis M 1998 Reference values of body composition obtained obtained by dual energy x-ray absorsptiometry in preterm and term neonates. J Pediatr Gastroenterol Nutr 27:184-190
13. Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, Herzog DB, Klibanski A 2006 Elevated Peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91:1027-1033
14. 3-36. N Engl J Med 349:941-948
15. Stock S, Leichner P, Wong AC, Ghatei MA, Kieffer TJ, Bloom SR, Chanoine JP 2005 Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90:2161-2168
16. Bacha F, Arslanian SA 2006 Ghrelin and PYY in youth: are there race-related differences? J Clin Endocrinol Metab 91:3117-3122
17. 3-36. J Endocrinol 156:485-492
18. Adrian TE, Smith HA, Calvert SA, Aynsley-Green A, Bloom SR 1986 Elevated plasma peptide YY in human neonates and infants. Pediatr Res 20:1225-1227
19. Riediger T, Bothe C, Becskei C, Lutz TA 2004 Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Neuroendocrinology 79:317-326
20. Adams SH, Won WB, Schonhoff SE, Leiter AB, Paterniti JR 2004 Effects of peptide YY(3-36) on short-term food intake in mice are not affected by prevailing plasma ghrelin levels. Endocrinology 145:4967-4975
21. Guo Y, Ma L, Enriori PJ, Koska J, Franks PW, Brookshire T, Cowley MA, Salbe AD, DelParigi A, Tataranni PA 2006 Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans. Obesity (Silver Spring) 14:1562-1570
22. 3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 53:1949-1952
23. Liu CD, Aloia T, Adrian TE, Newton TR, Bilchik AJ, Zinner MJ, Ashley SW, McFadden DW 1996 Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders. Am Surg 62:232-236
24. Mannon PJ 2002 Peptide YY as a growth factor for intestinal epithelium. Peptides 23:383-388
25. Gomez G, Zhang T, Rajaraman S, Thakore KN, Yanaihara N, Townsend CM Thompson JC, Greeley GH 1995 Intestinal peptide YY: ontogeny of gene expression in rat bowel and trophic actions on rat and mouse bowel. Am J Physiol 268:G71-G81
26. Castan I, Valet P, Larrouy D, Voisin T, Remaury A, Daviaud D, Laburthe M, Lafontan M 1993 Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system. Am J Physiol 265:E74-E80